drugset / Trial / NCT00504725

Ketamine In Thoracic Surgery (KITS) Trial

NCT00504725 ↗

Phase 2 Completed 40 enrolled Duke University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary aim of the study is to demonstrate a reduction in circulating interleukin 6 levels at 4 and 24 hours after completion of lobectomy (either VATS or open). The null hypothesis (H0) is thus that there is no difference in circulating interleukin 6 levels when patients are given either ketamine or placebo (0.9% saline in equivalent volume). The alternative (two tailed) hypothesis (HA) if the null is disproved is that ketamine leads to significantly different levels of interleukin 6 at 4 and 24 hours after completion of surgery. We plan to randomize 40 patients to receive either ketamine or placebo, in a block of 4 randomization design stratified by whether surgery is performed by VATS or open lobectomy.

Timeline

Start
2007-07
Primary completion
2007-12
Completion
2007-12

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Ketamine vs Placebo; p = 0.39; ANOVA NCT00504725 ↗

registry analysis (superiority or other test); Ketamine vs Placebo; p = 0.18; ANOVA NCT00504725 ↗

registry analysis (superiority or other test); Ketamine vs Placebo; p = 0.14; ANOVA NCT00504725 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous

Indications